Pieris Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Comprehensive Income (Loss)

Consolidated Statements of Comprehensive Income (Loss) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (9,849,964)us-gaap_NetIncomeLoss	$ 66,196us-gaap_NetIncomeLoss
Other comprehensive loss
Foreign currency translation adjustments	113,176	23,109
Total other comprehensive income (loss), after tax	113,176	23,109
Comprehensive income (loss) attributable to the owners of Pieris Pharmaceuticals, Inc.	$ (9,736,788)us-gaap_ComprehensiveIncomeNetOfTax	$ 89,305us-gaap_ComprehensiveIncomeNetOfTax

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

- Definition

Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References + Details